[go: up one dir, main page]

BRPI0603772A - composições para a inibição ou redução de inflamação da pele - Google Patents

composições para a inibição ou redução de inflamação da pele

Info

Publication number
BRPI0603772A
BRPI0603772A BRPI0603772-0A BRPI0603772A BRPI0603772A BR PI0603772 A BRPI0603772 A BR PI0603772A BR PI0603772 A BRPI0603772 A BR PI0603772A BR PI0603772 A BRPI0603772 A BR PI0603772A
Authority
BR
Brazil
Prior art keywords
compositions
skin inflammation
inhibiting
reducing skin
composition
Prior art date
Application number
BRPI0603772-0A
Other languages
English (en)
Inventor
Laura Magee
Frank Liebel
Michael Southall
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of BRPI0603772A publication Critical patent/BRPI0603772A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

COMPOSIçõES PARA INIBIçãO OU REDUçãO DE INFLAMAçãO DA PELE. A presente invenção refere-se a uma composição e métodos para o tratamento de inflamação da pele, onde a composição contém hidro-cortisona e uma avenantramida.
BRPI0603772-0A 2005-09-09 2006-09-08 composições para a inibição ou redução de inflamação da pele BRPI0603772A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/222,888 US20070059390A1 (en) 2005-09-09 2005-09-09 Compositions for inhibiting or reducing inflammation of skin

Publications (1)

Publication Number Publication Date
BRPI0603772A true BRPI0603772A (pt) 2007-06-12

Family

ID=37127908

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0603772-0A BRPI0603772A (pt) 2005-09-09 2006-09-08 composições para a inibição ou redução de inflamação da pele

Country Status (7)

Country Link
US (1) US20070059390A1 (pt)
EP (1) EP1762240A1 (pt)
JP (1) JP2007077146A (pt)
CN (1) CN1927209A (pt)
AU (1) AU2006208424A1 (pt)
BR (1) BRPI0603772A (pt)
CA (1) CA2559439A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070059268A1 (en) * 2005-09-09 2007-03-15 Laura Magee Compositions, methods and kits for treating allergic dermatitis of skin
US20070059679A1 (en) * 2005-09-09 2007-03-15 Michelle Garay Method for demonstrating efficacy of a topically applied active ingredient
WO2009059435A1 (en) * 2007-11-08 2009-05-14 Ceapro Inc. Avenanthramide-containing compositions
US8431142B2 (en) * 2011-05-18 2013-04-30 The Idea Folder, Llc Topical sanitizing gel containing avenanthramides
US9855222B2 (en) 2015-03-27 2018-01-02 The Idea Folder Llc Topical sanitizer that includes avenanthramides
CN105594704B (zh) * 2016-01-13 2017-02-22 中山爱护日用品有限公司 一种抑菌组合物及其在抑菌洗衣液中的应用
CN106474373A (zh) * 2016-11-14 2017-03-08 张昌红 一种肤肌散的新配方
KR102095199B1 (ko) * 2018-01-25 2020-04-02 전남대학교산학협력단 귀리 추출물 아베난쓰라마이드 c를 이용한 ampk 활성화 방법
WO2019179639A1 (en) * 2018-03-23 2019-09-26 Symrise Ag Skin condition improving agents
EP4114354B1 (en) * 2020-03-06 2024-12-11 Symrise AG Avenanthramide compositions with improved solubility comprising 4-hydroxyphenone
WO2025198136A1 (ko) * 2024-03-22 2025-09-25 주식회사 엘지생활건강 피부 장벽 강화용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2074402B1 (es) * 1993-12-31 1996-06-16 Cusi Lab Formulacion farmaceutica conteniendo difenhidramina, talco, calamina y extracto de avena, en una base emulsionada, y sus aplicaciones.
DE60042567D1 (de) 1999-05-06 2009-08-27 Ceapro Inc Avenanthramiden aus Haferextrakt enthaltende Zusammensetzungen
US6762158B2 (en) * 1999-07-01 2004-07-13 Johnson & Johnson Consumer Companies, Inc. Personal care compositions comprising liquid ester mixtures
KR20020027198A (ko) * 2000-10-02 2002-04-13 차알스 제이. 메츠 염증과 홍반의 완화방법
US6607735B2 (en) * 2000-12-21 2003-08-19 Johnson & Johnson Consumer Companies, Inc. Method for reducing the appearance of dark circles under the eyes
EP1367993B1 (en) * 2001-03-16 2007-05-16 Johnson & Johnson Consumer Companies, Inc. Use of a feverfew extract for regulating skin ageing factors
US6803056B2 (en) * 2001-09-14 2004-10-12 Terence M. Dolak Method and composition for treating viral outbreaks
DE10254872A1 (de) * 2002-11-25 2004-06-03 Symrise Gmbh & Co. Kg Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe
WO2005047833A1 (ja) 2003-11-14 2005-05-26 Olympus Corporation マルチスペクトル撮像装置、マルチスペクトル照明装置

Also Published As

Publication number Publication date
AU2006208424A1 (en) 2007-03-29
EP1762240A1 (en) 2007-03-14
US20070059390A1 (en) 2007-03-15
CN1927209A (zh) 2007-03-14
JP2007077146A (ja) 2007-03-29
CA2559439A1 (en) 2007-03-09

Similar Documents

Publication Publication Date Title
UA95310C2 (ru) Композиция, содержащая ингибитор chk1 и циклодекстрин, для лечения рака
EA200900819A1 (ru) Хиназолины для ингибирования pdk1
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
TNSN08400A1 (en) Organic compounds and their uses
BRPI1000320B8 (pt) Composições e métodos para tratar sinais de envelhecimento da pele
UA107783C2 (en) Isoindoline compounds for use in treating cancer
BR122019016628B8 (pt) uso de uma composição compreendendo um derivado de hidróxi de atorvastatina ou sal farmaceuticamente aceitável do mesmo e um óleo compreendendo etil eicosapentaenoato ou etil docosahexaenoato para a fabricação de um medicamento para o tratamento de uma doença cardiovascular
BRPI0407195A (pt) inibidor de histona desacetilase, composição, e, método para inibir histona desacetilase em uma célula
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
BR0304648A (pt) Combinação de inibidores de ciclooxigenase-2 e talidomida para o tratamento de neoplasia
WO2009147201A3 (en) Anti-inflammatory agents
MX2009005725A (es) Metodos y composiciones para tratamiento y monitoreo de tratamiento de trastornos asociados con il-13.
BRPI0519424A2 (pt) composiÇÕes e mÉtodos para tratamento de distérbios de proliferaÇço celular
HN2009001112A (es) Inhibidores de la actividad de la akt
EP2573069A3 (en) Inhibitors of histone deacetylase and prodrugs thereof
WO2007145704A3 (en) Gemcitabine combination therapy
WO2007053573A3 (en) Treatment of cancer with sorafenib
UY30220A1 (es) Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo
WO2007109105A3 (en) Flavivirus inhibition by sultams and related compounds
BRPI0712607A8 (pt) métodos de tratamento de acidente vascular cerebral
WO2009009417A3 (en) Pharmaceutical compositions and methods of preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion
EP2502996A3 (en) Anti-FGF23 antibody and pharmaceutical composition comprising the same
WO2008073332A3 (en) Creatine compositions for skin treatment
WO2005117846A3 (en) Ice inhibitors for the treatment of autoinflammatory diseases

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.